Related references
Note: Only part of the references are listed.Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction
Monique Vogel et al.
ALLERGY (2022)
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
Mona O. Mohsen et al.
ALLERGY (2022)
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Zijun Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Martin F. Bachmann et al.
NPJ VACCINES (2021)
The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 doublethink effect
Alessandro Manenti et al.
JOURNAL OF VIROLOGICAL METHODS (2021)
The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2
Georg Bauer
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced
Xinyue Chang et al.
ALLERGY (2021)
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
Lisha Zha et al.
VACCINES (2021)
COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact
David A. Swan et al.
SCIENTIFIC REPORTS (2021)
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
Mona O. Mohsen et al.
NPJ VACCINES (2021)
Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2
Kun Sun et al.
HELIYON (2021)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
The 3Ds in virus-like particle based-vaccines: Design, Delivery and Dynamics
Mona O. Mohsen et al.
IMMUNOLOGICAL REVIEWS (2020)
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples
Alessandro Manenti et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
Fran Robson et al.
MOLECULAR CELL (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
Michael W. Russell et al.
FRONTIERS IN IMMUNOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion
Caroline C. Krueger et al.
FRONTIERS IN IMMUNOLOGY (2019)
The establishment of resident memory B cells in the lung requires local antigen encounter
S. Rameeza Allie et al.
NATURE IMMUNOLOGY (2019)
Immune responses after live attenuated influenza vaccination
Kristin G. -I. Mohn et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy
Andris Zeltins et al.
NPJ VACCINES (2017)
Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection
Angela Pizzolla et al.
SCIENCE IMMUNOLOGY (2017)
Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
David A. G. Skibinski et al.
PLOS ONE (2013)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens
Edmund J. Gosselin et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses
Juliana Bessa et al.
JOURNAL OF IMMUNOLOGY (2009)
Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
Juliana Bessa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia
HP Jia et al.
JOURNAL OF VIROLOGY (2005)
Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG
A Rodríguez et al.
VACCINE (2005)
Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract
KB Renegar et al.
JOURNAL OF IMMUNOLOGY (2004)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Immunochemical analyses of serum antibodies from pig herds in a Salmonella non-endemic region
C Wiuff et al.
VETERINARY MICROBIOLOGY (2002)
Share Paper
